All Relations between Isoprenaline and hypertrophic

Reference Sentence Publish Date Extraction Date Species
James T Pearso. Set7 methyltransferase roles in myocardial protection from chronic stressors. Clinical science (London, England : 1979) vol 137 issue 1 2023 36601782 recent transcriptome and fourier transform infrared spectroscopy analyses and in vivo assessments of cardiac function by lunardon and colleagues now reveal a clear role of set7 in the regulation of the extracellular matrix composition and cardiac hypertrophy in response to chronic isoproterenol induced cardiac stress. 2023-01-05 2023-01-08 Not clear
Shrook Y Abdellatif, Nagui H Fares, Samar H Elsharkawy, Yomna I Mahmou. Calanus oil attenuates isoproterenol-induced cardiac hypertrophy by regulating myocardial remodeling and oxidative stress. Ultrastructural pathology vol issue 2023 36588172 cardiac hypertrophy was induced by subcutaneous injections with isoproterenol (5 mg/kg b.w) for 14 consecutive days. 2023-01-01 2023-01-05 Not clear
Hongming Li, Yumei Qiu, Mengdie Xie, Changsheng Ouyang, Xiaoyun Ding, Hao Zhang, Wei Dong, Yinhua Xiong, Xilan Tan. Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-\\xce\\xb6. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology vol 27 issue 1 2022 36575935 this study aimed to observe the protective effect of momordicine i, a triterpenoid compound extracted from momordica charantia l., on isoproterenol (iso)-induced hypertrophy in rat h9c2 cardiomyocytes and investigate its potential mechanism. 2022-12-28 2023-01-05 Not clear
Bo Liu, Beilei Qiu, Suchuan Zhan. Effect of Hesperetin on Isoprenaline-induced Hypertrophy of H9C2 Cardiomyocytes. Cellular and molecular biology (Noisy-le-Grand, France) vol 68 issue 7 2022 36495513 for this aim, h9c2 cardiomyocytes were coincubated with different concentrations of hesperetin (0.125, 0.25, 0.5, 1\xce\xbcmol/l) and isoproterenol to detect the changes in the area of h9c2 cells, the expression of cardiac hypertrophy marker \xce\xb2-mhc mrna and autophagy marker lc3ii; h9c2 cells were coincubated with hesperetin and isoproterenol at the optimal intervention concentration, and the intervention time was set to 6h, 12h, 24h, respectively, and the changes of h9c2 cell area, \xce\xb2-mhc mrna and lc3ii expression were detected. 2022-12-10 2022-12-15 Not clear
Bo Liu, Beilei Qiu, Suchuan Zhan. Effect of Hesperetin on Isoprenaline-induced Hypertrophy of H9C2 Cardiomyocytes. Cellular and molecular biology (Noisy-le-Grand, France) vol 68 issue 7 2022 36495513 conclusion hesperetin may improve the hypertrophy of h9c2 cardiomyocytes induced by isoproterenol by activating autophagy. 2022-12-10 2022-12-15 Not clear
Guilherme Lunardon, T\\xc3\\xa1batha de Oliveira Silva, Caroline A Lino, Yao Wei Lu, Juliane B Miranda, Paula F Asprino, Amanda de Almeida Silva, Gabrielle T Nepomuceno, Maria Cl\\xc3\\xa1udia Costa Irigoyen, Marcela S Carneiro-Ramos, Ana Paula C Takano, Herculano da Silva Martinho, Maria Luiza M Barreto-Chaves, Da-Zhi Wang, Gabriela P Dini. Set7 deletion attenuates isoproterenol-induced cardiac fibrosis and delays cardiac dysfunction. Clinical science (London, England : 1979) vol issue 2022 36285636 in addition, wt and set7 ko mice injected with isoproterenol exhibited cardiac hypertrophy. 2022-10-26 2022-11-01 Not clear
Guilherme Lunardon, T\\xc3\\xa1batha de Oliveira Silva, Caroline A Lino, Yao Wei Lu, Juliane B Miranda, Paula F Asprino, Amanda de Almeida Silva, Gabrielle T Nepomuceno, Maria Cl\\xc3\\xa1udia Costa Irigoyen, Marcela S Carneiro-Ramos, Ana Paula C Takano, Herculano da Silva Martinho, Maria Luiza M Barreto-Chaves, Da-Zhi Wang, Gabriela P Dini. Set7 deletion attenuates isoproterenol-induced cardiac fibrosis and delays cardiac dysfunction. Clinical science (London, England : 1979) vol issue 2022 36285636 interestingly, set7 deletion exacerbated cardiac hypertrophy in response to isoproterenol, but attenuated myocardial fibrosis. 2022-10-26 2022-11-01 Not clear
Sitong Ming, Mo Kan, Liu Liu, Zhuang Zhang, Xiaoran Liu, Yaxin Liu, Zhen Li, Yanhong Zhang, Qihang Pang, Jianan Lin, Hui Li, Qing Yang, Xin Sui, Xiaobo Qu, Na L. Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA. Evidence-based complementary and alternative medicine : eCAM vol 2022 issue 2022 36118100 therefore, this study aimed to investigate the protective effect and mechanism of smy on isoproterenol (iso)-induced myocardial hypertrophy in rats. 2022-09-19 2022-09-29 Not clear
Ting-Ting Yu, Li-Jun Sun, Chen Chen, Zi-Jian Wang, Xue-Sheng Liu, Feng-Qin Zhu, Shan Ga. Xin-Ji-Er-Kang Alleviates Isoproterenol-Induced Myocardial Hypertrophy in Mice through the Nrf2/HO-1 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM vol 2022 issue 2022 36045660 we hypothesized that xjek may prevent isoproterenol (iso)-induced myocardial hypertrophy (mh) in mice by ameliorating oxidative stress (os) through a mechanism that may be related to the nuclear factor erythroid 2-related factor 2 (nrf2)/heme oxygenase-1(ho-1) pathways. 2022-09-01 2022-09-06 Not clear
Faiza Shaikh, Lokesh Kumar Bhat. Cardioprotective effect of Polymyxin-B and Dantrolene combination on isoproterenol-induced hypertrophic cardiomyopathy in rats, via attenuation of Calmodulin-dependent protein kinase II. Chemistry & biodiversity vol issue 2022 36037238 administration of isoproterenol for 14 days resulted in severe myocardial damage, characterized by cardiac hypertrophy and increase serum ck-mb, ck-nac, ldh, ast, and alt levels. 2022-08-29 2022-08-31 Not clear
Li Xu, Qiong Liu, Tianyi Long, Liming Peng, Fei Li, Zelin Sun, Qiying Xi. Ectopic Acsl6 overexpression partially improves Isoproterenol (ISO)-induced cardiac hypertrophy in vivo and cardiomyocyte hypertrophy in vitro. Journal of cardiovascular pharmacology vol issue 2022 35976155 ectopic acsl6 overexpression partially improves isoproterenol (iso)-induced cardiac hypertrophy in vivo and cardiomyocyte hypertrophy in vitro. 2022-08-17 2022-08-22 Not clear
Li Xu, Qiong Liu, Tianyi Long, Liming Peng, Fei Li, Zelin Sun, Qiying Xi. Ectopic Acsl6 overexpression partially improves Isoproterenol (ISO)-induced cardiac hypertrophy in vivo and cardiomyocyte hypertrophy in vitro. Journal of cardiovascular pharmacology vol issue 2022 35976155 based on experimental data, acsl6 was underexpressed in iso-induced cardiac hypertrophy mouse model and isoproterenol (iso)-induced cardiomyocyte hypertrophy cell model. 2022-08-17 2022-08-22 Not clear
Prabha Burman, Rahul Jaiswal, Kusum Devi, Baisakhi Moharan. Aurintricarboxylic Acid Protects Isoproterenol Induced Left Ventricular Hypertrophy by Modulating TWEAK Signaling. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology vol issue 2022 35977688 aurintricarboxylic acid protects isoproterenol induced left ventricular hypertrophy by modulating tweak signaling. 2022-08-17 2022-08-22 Not clear
Prabha Burman, Rahul Jaiswal, Kusum Devi, Baisakhi Moharan. Aurintricarboxylic Acid Protects Isoproterenol Induced Left Ventricular Hypertrophy by Modulating TWEAK Signaling. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology vol issue 2022 35977688 in this study, we investigated the effect of ata on isoproterenol (iso)-induced pathological cardiac hypertrophy. 2022-08-17 2022-08-22 Not clear
Jian Wang, Yucheng An, Jun Lin, Gang Tan. MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells. Annals of translational medicine vol 10 issue 14 2022 35965805 this study explored the effects of microrna(mir)-194 on chronic cardiac hypertrophy (ch) induced by isoproterenol (iso). 2022-08-15 2022-08-22 Not clear
Farogh Ahsan, Tarique Mahmood, Tanveer A Wani, Seema Zargar, Mohammed Haris Siddiqui, Shazia Usmani, Arshiya Shamim, Muhammad Wahajuddi. Effectual Endeavors of Silk Protein Sericin against Isoproterenol Induced Cardiac Toxicity and Hypertrophy in Wistar Rats. Life (Basel, Switzerland) vol 12 issue 7 2022 35888151 effectual endeavors of silk protein sericin against isoproterenol induced cardiac toxicity and hypertrophy in wistar rats. 2022-07-27 2022-08-08 Not clear
Zhenhuan Chen, Haiwen Zhou, Xiantao Huang, Shaoyun Wang, Xiaochao Ouyang, Yunxia Wang, Qianqiang Cao, Liu Yang, Yu Tao, Hengli La. Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway. Bioengineered vol 13 issue 5 2022 35609321 pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (jak-2/stat3) signaling pathway. 2022-05-24 2022-06-13 Not clear
Jacob Russell, Chastidy Bailey, Scott Brown, Vincent G DeMarco, Srinivas Mummidi, Shawn B Bender, Bysani Chandraseka. Minocycline Blunts Isoproterenol-Induced Cardiac Hypertrophy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol 36 Suppl 1 issue 2022 35556049 here we investigated whether chronic administration of isoproterenol (iso), a \xce\xb2-ar agonist, would promote hypertrophy, fibrosis, and dysfunction, and whether these maladaptive changes are prevented by minocycline, an fda-approved antibiotic, that has been shown to have cardioprotective effects outside of its antibacterial properties. 2022-05-13 2022-06-13 Not clear
Suxia Guo, Yanhua Yang, Weichun Qian, Yongzhao Yao, Guoxiang Zhou, Lihan Shen, Jianping Zho. MicroRNA-384-5p protects against cardiac hypertrophy via the ALPK3 signaling pathway. Journal of biochemical and molecular toxicology vol issue 2022 35510648 in this study, cardiac hypertrophy models were constructed using isoproterenol (iso)-/angiotensin-ii (ang-ii) to explore the role of mir-384-5p in cardiac hypertrophy and its molecular mechanism in vivo and in vitro. 2022-05-05 2022-05-07 Not clear
S Shervin Prince, P Stanely Mainzen Prince, V M Berlin Grac. Valencene post-treatment exhibits cardioprotection via inhibiting cardiac hypertrophy, oxidative stress, nuclear factor- \\xce\\xbaB inflammatory pathway, and myocardial infarct size in isoproterenol-induced myocardial infarcted rats; A molecular study. European journal of pharmacology vol issue 2022 35469837 rats were induced mi by isoproterenol (100\xe2\x80\xafmg/kg body weight) and then treated with valencene and cardiac sensitive markers, cardiac hypertrophy, oxidative stress, markers of inflammation, nuclear factor- \xce\xbab inflammatory pathway, and myocardial infarct size was estimated/determined. 2022-04-26 2022-04-30 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25